LIFE Stock Overview
Engages in the research and development of medical sensors for health monitoring in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Lifecare AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.09 |
| 52 Week High | kr6.32 |
| 52 Week Low | kr1.42 |
| Beta | -0.060 |
| 1 Month Change | -31.70% |
| 3 Month Change | -37.80% |
| 1 Year Change | 3.98% |
| 3 Year Change | -31.48% |
| 5 Year Change | 39.33% |
| Change since IPO | 0.48% |
Recent News & Updates
Shareholder Returns
| LIFE | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | -15.2% | -1.1% | 0.6% |
| 1Y | 4.0% | 6.5% | 8.0% |
Return vs Industry: LIFE underperformed the Norwegian Medical Equipment industry which returned 6.5% over the past year.
Return vs Market: LIFE underperformed the Norwegian Market which returned 8.9% over the past year.
Price Volatility
| LIFE volatility | |
|---|---|
| LIFE Average Weekly Movement | 24.9% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in NO Market | 10.8% |
| 10% least volatile stocks in NO Market | 3.1% |
Stable Share Price: LIFE's share price has been volatile over the past 3 months.
Volatility Over Time: LIFE's weekly volatility has increased from 16% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 33 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
| LIFE fundamental statistics | |
|---|---|
| Market cap | kr281.87m |
| Earnings (TTM) | -kr41.82m |
| Revenue (TTM) | kr10.89m |
25.9x
P/S Ratio-6.7x
P/E RatioIs LIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LIFE income statement (TTM) | |
|---|---|
| Revenue | kr10.89m |
| Cost of Revenue | kr0 |
| Gross Profit | kr10.89m |
| Other Expenses | kr52.70m |
| Earnings | -kr41.82m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 100.00% |
| Net Profit Margin | -384.12% |
| Debt/Equity Ratio | 4.4% |
How did LIFE perform over the long term?
See historical performance and comparison